Evaluate the Performance of JOURNEY II CR in TKA Populations (JIICRTKA)
A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II CR Total Knee System
Sponsor: Smith & Nephew, Inc.
Terminated
It was terminated by sponsor for updated evidence needs
Other terminated trials from Smith & Nephew, Inc.
- Acute Wounds · Oct 2025
- Meniscus Tear · Apr 2024
- Avascular Necrosis · Phase NA · Feb 2024
- Osteoarthritis of the Shoulder · Dec 2023
- Rotator Cuff Injuries · Phase NA · Oct 2023
More terminations from Smith & Nephew, Inc.
Other Arthroplasty trials with similar outcome
This observational or N/A phase trial investigates Arthroplasty and Knee and is currently terminated or withdrawn. Smith & Nephew, Inc. leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Recruiting
-
Aug 2023 — Nov 2023 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jul 2022 — Aug 2023 [monthly]
Recruiting
-
Dec 2021 — Jul 2022 [monthly]
Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Smith & Nephew, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .